4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000950170-25-085454
Options or other derivatives
- Director acquired 70,207 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Bronstein Ben Director | 2025-06-10 | Grant or award · Stock Option (Right to Buy) | +62,728 | 62,728 | D | ||
| Bronstein Ben Director | 2025-06-10 | Grant or award · Stock Option (Right to Buy) | +3,619 | 3,619 | D | ||
| Bronstein Ben Director | 2024-06-10 | Grant or award · Stock Option (Right to Buy) | +3,860 | 3,860 | D | ||
Loading xslF345X05/ownership.xml…